{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:23:56Z","timestamp":1788866636771,"version":"build-2803163510"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Kidney diseases represent a diverse group of disorders with pathogenic mechanisms involving multiple pathological processes, including inflammation, immunity, and cell death. Neutrophils, as primary effector cells in inflammatory immune responses, participate in defending against renal infection and injury by releasing reactive oxygen species, proteases, and cytokines. However, persistent neutrophil activation is considered a crucial driver of kidney disease progression. Neutrophil apoptosis represents a critical turning point between inflammatory progression and resolution. Specialized pro-resolving mediators (SPMs) are endogenous anti-inflammatory mediators that play a critical role in resolving inflammation. They not only induce neutrophil programmed cell death and promote macrophage-mediated efferocytosis of apoptotic cells but also inhibit neutrophil infiltration and degranulation, ultimately facilitating the restoration of inflammatory microenvironment and tissue homeostasis. This review concentrates on elucidating the mechanisms by which SPMs regulate neutrophil apoptosis and systematically demonstrates their potential as novel therapeutic targets in kidney diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1589923","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:12:04Z","timestamp":1747282324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Specialized pro-resolving mediators in neutrophil apoptosis regulation: unlocking novel therapeutic potential in kidney diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Yi","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.3390\/jcm13092455","article-title":"Treatment of acute kidney injury: A review of current approaches and emerging innovations","volume":"13","author":"Tamargo","year":"2024","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074216","article-title":"Advances in the management of chronic kidney disease","volume":"383","author":"Chen","year":"2023","journal-title":"Bmj"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways\u00a0in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/antiox13060659","article-title":"Advance in iron metabolism, oxidative stress and cellular dysfunction in experimental and human kidney diseases","volume":"13","author":"Xie","year":"2024","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113965","DOI":"10.1016\/j.addr.2021.113965","article-title":"Therapeutic potential of pro-resolving mediators in diabetic kidney disease","volume":"178","author":"Vartak","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"118615","DOI":"10.1016\/j.atherosclerosis.2024.118615","article-title":"The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies","volume":"398","author":"Giardini","year":"2024","journal-title":"Atherosclerosis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866747","article-title":"Targeting neutrophils for promoting the resolution of inflammation","volume":"13","author":"Filep","year":"2022","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1600-065X.2010.00922.x","article-title":"Targeting granulocyte apoptosis: mechanisms, models, and therapies","volume":"236","author":"Duffin","year":"2010","journal-title":"Immunological Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0511222","article-title":"Editorial: Neutrophil apoptosis: hot on the TRAIL of inflammatory resolution","volume":"90","author":"Leitch","year":"2011","journal-title":"J leukocyte Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000822","article-title":"Lipid mediators in neutrophil biology: inflammation, resolution and beyond","volume":"31","author":"Ghodsi","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/antiox10060933","article-title":"Specialized pro-resolving lipid mediators in neonatal cardiovascular physiology and diseases","volume":"10","author":"Gila-Diaz","year":"2021","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12730","article-title":"Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction","volume":"7","author":"Halade","year":"2020","journal-title":"ESC Heart failure"},{"key":"B15","doi-asserted-by":"publisher","first-page":"106990","DOI":"10.1016\/j.prostaglandins.2025.106990","article-title":"Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study","volume":"178","author":"Wang","year":"2025","journal-title":"Prostaglandins other Lipid Mediators"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01488","article-title":"Specialized pro-resolving lipid mediators: modulation of diabetes-associated cardio-, reno-, and retino-vascular complications","volume":"9","author":"de Gaetano","year":"2018","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.780811","article-title":"Role of specialized pro-resolving mediators in reducing neuroinflammation in neurodegenerative disorders","volume":"14","author":"Ponce","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.704163","article-title":"Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation","volume":"12","author":"Hasturk","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/s41467-020-19176-z","article-title":"Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis","volume":"11","author":"Gomez","year":"2020","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2017.05.001","article-title":"Specialized pro-resolving mediators in renal fibrosis","volume":"58","author":"Brennan","year":"2017","journal-title":"Mol aspects Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/molecules29102233","article-title":"Advances in the chemistry and biology of specialised pro-resolving mediators (SPMs)","volume":"29","author":"Byrne","year":"2024","journal-title":"Molecules (Basel Switzerland)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.3390\/ijms24076749","article-title":"Dysregulation of resolvin E1 metabolism and signaling in a light-damage model of age-related macular degeneration","volume":"24","author":"Tisi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-051821-042743","article-title":"Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation","volume":"63","author":"Perretti","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"102352","DOI":"10.1016\/j.arr.2024.102352","article-title":"Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension","volume":"99","author":"Zhang","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the resolution of the inflammatory response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/prd.2013.63.issue-1","article-title":"Natural resolution of inflammation","volume":"63","author":"Freire","year":"2013","journal-title":"Periodontology 2000"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: An organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01192","article-title":"Inflammation in renal diseases: new and old players","volume":"10","author":"Andrade-Oliveira","year":"2019","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.984362","article-title":"Annexin A1 exerts renoprotective effects in experimental crescentic glomerulonephritis","volume":"13","author":"Labes","year":"2022","journal-title":"Front Physiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"158940","DOI":"10.1016\/j.bbalip.2021.158940","article-title":"Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases","volume":"1866","author":"Andrews","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080671","article-title":"Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis","volume":"174","author":"Wu","year":"2009","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.02.025","article-title":"Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy","volume":"100","author":"Wu","year":"2021","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168728","article-title":"Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis","volume":"8","author":"Norling","year":"2023","journal-title":"JCI Insight"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Kooij","year":"2020","journal-title":"Haematologica"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91486-4","article-title":"Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes","volume":"118","author":"Serhan","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1476-511X-10-76","article-title":"Lipoxins as biomarkers of lupus and other inflammatory conditions","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000119962.69573.CC","article-title":"Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis","volume":"15","author":"Ohse","year":"2004","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13450","DOI":"10.1111\/obr.13450","article-title":"Obesity-related glomerulopathy: Current approaches and future perspectives","volume":"23","author":"Mart\u00ednez-Montoro","year":"2022","journal-title":"Obesity reviews: an Off J Int Assoc Study Obesity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802587R","article-title":"Leukocytes from obese individuals exhibit an impaired SPM signature","volume":"33","author":"L\u00f3pez-Vicario","year":"2019","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.02.039","article-title":"Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-\u03baB and ERK\/p38 MAPK-dependent inflammation","volume":"198","author":"Guo","year":"2018","journal-title":"Life Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease","volume":"22","author":"B\u00f6rgeson","year":"2015","journal-title":"Cell Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914860","article-title":"Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor \u03b2 (TGF-\u03b2)\/smad pathway and pro-inflammatory cytokines","volume":"25","author":"Bai","year":"2019","journal-title":"Med Sci monitor: Int Med J Exp Clin Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0050","article-title":"The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK\/PPAR\u03b1\/CPT1b pathway","volume":"70","author":"Wu","year":"2021","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4469-y","article-title":"Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes","volume":"61","author":"Purvis","year":"2018","journal-title":"Diabetologia"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.05.027","article-title":"Annexin A1 concentrations is decreased in patients with diabetes type 2 and nephropathy","volume":"436","author":"Pietrani","year":"2014","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202007_21913","article-title":"Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential","volume":"24","author":"Li","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.jlr.2021.100120","article-title":"Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy","volume":"62","author":"Morita","year":"2021","journal-title":"J Lipid Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"7177889","DOI":"10.1155\/2022\/7177889","article-title":"Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2438247","DOI":"10.1155\/2017\/2438247","article-title":"Maresin 1 mitigates high glucose-induced mouse glomerular mesangial cell injury by inhibiting inflammation and fibrosis","volume":"2017","author":"Tang","year":"2017","journal-title":"Mediators Inflammation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13173","article-title":"Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health\/disease status","volume":"46","author":"Tob\u00f3n-Arroyave","year":"2019","journal-title":"J Clin periodontology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009318","article-title":"Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS\/STING pathway","volume":"12","author":"Hou","year":"2024","journal-title":"J immunotherapy Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","article-title":"Therapeutic potential of lipoxin A(4) in chronic inflammation: focus on cardiometabolic disease","volume":"3","author":"Fu","year":"2020","journal-title":"ACS Pharmacol Trans Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"113167","DOI":"10.1016\/j.ejmech.2021.113167","article-title":"Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential","volume":"213","author":"Maciuszek","year":"2021","journal-title":"Eur J medicinal Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/bph.v181.22","article-title":"Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists","volume":"181","author":"Peng","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"110167","DOI":"10.1016\/j.clim.2024.110167","article-title":"LXA4 protected mice from renal ischemia\/reperfusion injury by promoting IRG1\/Nrf2 and IRAK-M-TRAF6 signal pathways","volume":"261","author":"Tie","year":"2024","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S188654","article-title":"Maresin 1 mitigates renal ischemia\/reperfusion injury in mice via inhibition of the TLR4\/MAPK\/NF-\u03baB pathways and activation of the Nrf2 pathway","volume":"13","author":"Qiu","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802064","article-title":"Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1","volume":"182","author":"Hassan","year":"2009","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000015795.74094.91","article-title":"15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure","volume":"13","author":"Leonard","year":"2002","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111634","article-title":"ATRvD1 attenuates renal tubulointerstitial injury induced by albumin overload in sepsis-surviving mice","volume":"22","author":"Silva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.12.029","article-title":"Effects of AT-RvD1 on paraquat-induced acute renal injury in mice","volume":"67","author":"Hu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.301200","article-title":"Aspirin-triggered lipoxin protects lipopolysaccharide-induced acute kidney injury via the TLR4\/myD88\/NF-\u03baB pathway","volume":"31","author":"Zhang","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637753","article-title":"Lipoxin A4 restores septic renal function via blocking crosstalk between inflammation and premature senescence","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067471","article-title":"Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3\u03b2 acetylation","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis","volume":"25","author":"B\u00f6rgeson","year":"2011","journal-title":"FASEB J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2337\/dbi21-0030","article-title":"Annexin 1 mimetic ac2\u201326 holds promise for the treatment of diabetic nephropathy","volume":"70","author":"Pan","year":"2021","journal-title":"Diabetes"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2015.04.013","article-title":"Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats","volume":"35","author":"de Assis","year":"2015","journal-title":"Nutr Res (New York NY)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clnu.2015.11.003","article-title":"Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial","volume":"36","author":"Soleimani","year":"2017","journal-title":"Clin Nutr (Edinburgh Scotland)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004740","article-title":"Eicosapentaenoic and docosahexaenoic acids attenuate progression of albuminuria in patients with type 2 diabetes mellitus and coronary artery disease","volume":"6","author":"Elajami","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-019-03058-y","article-title":"Dietary DHA\/EPA supplementation ameliorates diabetic nephropathy by protecting from distal tubular cell damage","volume":"378","author":"Vitlov Uljevi\u0107","year":"2019","journal-title":"Cell Tissue Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clin Nutr (Edinburgh Scotland)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e21559","DOI":"10.1096\/fj.202100073R","article-title":"Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice","volume":"35","author":"Perazza","year":"2021","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00217.2009","article-title":"Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney","volume":"297","author":"An","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000441051.36783.f3","article-title":"The link between acute kidney injury and chronic kidney disease","volume":"23","author":"Belayev","year":"2014","journal-title":"Curr Opin Nephrol hypertension"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030222","article-title":"Yes, AKI truly leads to CKD","volume":"23","author":"Hsu","year":"2012","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-option of neutrophil fates by tissue environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1159\/000284367","article-title":"Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease","volume":"2","author":"Fox","year":"2010","journal-title":"J innate Immun"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2011.75","article-title":"Peculiarities of cell death mechanisms in neutrophils","volume":"18","author":"Geering","year":"2011","journal-title":"Cell Death differentiation"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385696","article-title":"Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70375-6","article-title":"Neutrophils and renal failure","volume":"34","author":"Heinzelmann","year":"1999","journal-title":"Am J Kidney diseases: Off J Natl Kidney Foundation"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nm1248","article-title":"Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis","volume":"11","author":"Jonsson","year":"2005","journal-title":"Nat Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000074486","article-title":"Apoptosis of neutrophils","volume":"111","author":"Maianski","year":"2004","journal-title":"Acta haematologica"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.1998.2540439.x","article-title":"Apoptosis signaling by death receptors","volume":"254","author":"Schulze-Osthoff","year":"1998","journal-title":"Eur J Biochem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1084\/jem.187.4.587","article-title":"Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis","volume":"187","author":"Hirata","year":"1998","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81266-0","article-title":"FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death\u2013inducing signaling complex","volume":"85","author":"Muzio","year":"1996","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.144.2.281","article-title":"Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner","volume":"144","author":"Slee","year":"1999","journal-title":"J Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1134\/S0022093021030017","article-title":"Molecular mechanisms for regulation of neutrophil apoptosis under normal and pathological conditions","volume":"57","author":"Noseykina","year":"2021","journal-title":"J evolutionary Biochem Physiol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2013.39789","article-title":"Neutrophil apoptosis: impact of granulocyte macrophage colony stimulating factor on cell survival and viability in chronic kidney disease and hemodialysis patients","volume":"9","author":"Zahran","year":"2013","journal-title":"Arch Med science: AMS"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1038\/s41467-019-10903-9","article-title":"IFN-\u03b2 is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation","volume":"10","author":"Kumaran Satyanarayanan","year":"2019","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-264903","article-title":"Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity","volume":"116","author":"Bhatnagar","year":"2010","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-287243","article-title":"Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3","volume":"117","author":"Costantini","year":"2011","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-848465","article-title":"Interaction with an endothelial lumen increases neutrophil lifetime and motility in response to P aeruginosa","volume":"132","author":"Hind","year":"2018","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.815412","article-title":"NET release of long-term surviving neutrophils","volume":"13","author":"Kolman","year":"2022","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2010.169","article-title":"Role of neutrophil apoptosis in the resolution of inflammation","volume":"10","author":"El Kebir","year":"2010","journal-title":"TheScientificWorldJournal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0905496","article-title":"Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration","volume":"79","author":"Buckley","year":"2006","journal-title":"J leukocyte Biol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/toxins11020073","article-title":"High-density lipoprotein from chronic kidney disease patients modulates polymorphonuclear leukocytes","volume":"11","author":"Raupachova","year":"2019","journal-title":"Toxins"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1532\/LH96.07003","article-title":"Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus","volume":"13","author":"Sudo","year":"2007","journal-title":"Lab hematology: Off Publ Int Soc Lab Hematol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41588-023-01600-x","article-title":"Perturbational phenotyping of human blood cells reveals genetically determined latent traits associated with subsets of common diseases","volume":"56","author":"Homilius","year":"2024","journal-title":"Nat Genet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12902-020-00597-2","article-title":"Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes","volume":"20","author":"Yu","year":"2020","journal-title":"BMC endocrine Disord"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13292","article-title":"Increased neutrophil count Is associated with the development of chronic kidney disease in patients with diabetes","volume":"14","author":"Zhang","year":"2022","journal-title":"J Diabetes"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.8.4286","article-title":"Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways","volume":"164","author":"Klein","year":"2000","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401313","article-title":"Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines","volume":"193","author":"Arnardottir","year":"2014","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.smim.2018.09.002","article-title":"Pro-resolving lipid mediators: Agents of anti-ageing","volume":"40","author":"Doyle","year":"2018","journal-title":"Semin Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1201651","article-title":"Neutrophil heterogeneity and aging: implications for COVID-19 and wound healing","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01037-7","article-title":"Efferocytosis in atherosclerosis","volume":"21","author":"Adkar","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ijms22020559","article-title":"Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease","volume":"22","author":"Klopf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-00944-3","article-title":"Neutrophils and NETs in kidney disease","author":"Nakazawa","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.10.1616","article-title":"Fate of neutrophils during the recovery phase of ischemia\/reperfusion induced acute kidney injury","volume":"32","author":"Cho","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.kint.2019.02.017","article-title":"Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance","volume":"96","author":"Everts-Graber","year":"2019","journal-title":"Kidney Int"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.5414\/CNP65309","article-title":"Apoptosis, proliferation and inflammatory infiltration in ANCA-positive glomerulonephritis","volume":"65","author":"Kettritz","year":"2006","journal-title":"Clin Nephrol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2000.00364.x","article-title":"CD44-mediated neutrophil apoptosis in the rat","volume":"58","author":"Takazoe","year":"2000","journal-title":"Kidney Int"},{"key":"B123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000515461","article-title":"Infection-related glomerulonephritis","volume":"1","author":"Khalighi","year":"2021","journal-title":"Glomerular Dis"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-06162-y","article-title":"Apoptosis in post-streptococcal glomerulonephritis and mechanisms for failed of inflammation resolution","volume":"39","author":"Mosquera-Sulbaran","year":"2024","journal-title":"Pediatr Nephrol (Berlin Germany)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669162","article-title":"Acute kidney injury induced lupus exacerbation through the enhanced neutrophil extracellular traps (and apoptosis) in fcgr2b deficient lupus mice with renal ischemia reperfusion injury","volume":"12","author":"Saisorn","year":"2021","journal-title":"Front Immunol"},{"key":"B126","article-title":"Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis","volume":"150","author":"Hughes","year":"1997","journal-title":"Am J Pathol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.8.x","article-title":"Immunoglobulin light chains in uremia","volume":"84","author":"Cohen","year":"2003","journal-title":"Kidney Int Supplement"},{"key":"B128","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms24010016","article-title":"Resolution potential of necrotic cell death pathways","volume":"24","author":"M\u00e1zl\u00f3","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: an integrated view","volume":"5","author":"Ortega-G\u00f3mez","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2015.03.014","article-title":"The resolution of inflammation: Principles and challenges","volume":"27","author":"Headland","year":"2015","journal-title":"Semin Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.10.065","article-title":"Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery","volume":"83","author":"Chello","year":"2007","journal-title":"Ann thoracic Surg"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2012.80","article-title":"Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation","volume":"19","author":"Leitch","year":"2012","journal-title":"Cell Death differentiation"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1006\/cbir.1999.0468","article-title":"Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis","volume":"24","author":"Perretti","year":"2000","journal-title":"Cell Biol Int"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.9b01282","article-title":"Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke","volume":"19","author":"Tang","year":"2019","journal-title":"Nano Lett"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.03.004","article-title":"Human neutrophils in auto-immunity","volume":"28","author":"Thieblemont","year":"2016","journal-title":"Semin Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140533","article-title":"Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles","volume":"112","author":"Dalli","year":"2008","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nat Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e2306457","DOI":"10.1002\/advs.202306457","article-title":"Dying to defend: neutrophil death pathways and their implications in immunity","volume":"11","author":"Tu","year":"2024","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27841","article-title":"Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatology (Baltimore Md)"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0112008","article-title":"Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis","volume":"92","author":"Vago","year":"2012","journal-title":"J leukocyte Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1206641109","article-title":"Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation","volume":"109","author":"El Kebir","year":"2012","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.20131104","article-title":"Protectin D1 promotes resolution of inflammation in a murine model of lipopolysaccharide-induced acute lung injury via enhancing neutrophil apoptosis","volume":"127","author":"Li","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000000434","article-title":"MARESIN 1 PREVENTS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL SURVIVAL AND ACCELERATES RESOLUTION OF ACUTE LUNG INJURY","volume":"44","author":"Gong","year":"2015","journal-title":"Shock (Augusta Ga)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.02.090","article-title":"The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia\/reperfusion injury by attenuating the pro-inflammatory response","volume":"472","author":"Xian","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920193117","article-title":"15-Epi-LXA(4) and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation","volume":"117","author":"Sekheri","year":"2020","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200810-1601OC","article-title":"15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury","volume":"180","author":"El Kebir","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"2426138","DOI":"10.1155\/2018\/2426138","article-title":"Metabolism plays a key role during macrophage activation","volume":"2018","author":"Stunault","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/nature10340","article-title":"Continued clearance of apoptotic cells critically depends on the phagocyte Ucp2 protein","volume":"477","author":"Park","year":"2011","journal-title":"Nature"},{"key":"B152","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00004","article-title":"New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation","volume":"3","author":"Ariel","year":"2012","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1042\/bst0320507","article-title":"Annexin 1 and neutrophil apoptosis","volume":"32","author":"Perretti","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(03)00090-X","article-title":"Annexin I is an endogenous ligand that mediates apoptotic cell engulfment","volume":"4","author":"Arur","year":"2003","journal-title":"Dev Cell"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4595","article-title":"Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages","volume":"178","author":"Scannell","year":"2007","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-865378","article-title":"Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1","volume":"133","author":"Matte","year":"2019","journal-title":"Blood"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J Biol Chem"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J Clin Invest"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1453","article-title":"Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution","volume":"7","author":"Trilleaud","year":"2021","journal-title":"Sci Adv"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387566","article-title":"GPCRs overexpression and impaired fMLP-induced functions in neutrophils from chronic kidney disease patients","volume":"15","author":"Scharf","year":"2024","journal-title":"Front Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"8318","DOI":"10.3390\/ijms24098318","article-title":"Mechanisms limiting renal tissue protection and repair in glomerulonephritis","volume":"24","author":"Angeletti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701173RR","article-title":"Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure","volume":"32","author":"Halade","year":"2018","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210134","article-title":"Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis","volume":"73","author":"Gray","year":"2018","journal-title":"Thorax"},{"key":"B168","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12931-022-02065-y","article-title":"Delayed neutrophil apoptosis may enhance NET formation in ARDS","volume":"23","author":"Song","year":"2022","journal-title":"Respir Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1164\/rccm.201903-0707LE","article-title":"Promoting neutrophil apoptosis to treat acute lung injury","volume":"200","author":"Kurdowska","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044340","article-title":"Loss of protease-activated receptor 4 prevents inflammation resolution and predisposes the heart to cardiac rupture after myocardial infarction","volume":"142","author":"Kolpakov","year":"2020","journal-title":"Circulation"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2021.08.008","article-title":"Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution","volume":"9","author":"Bao","year":"2022","journal-title":"Bioactive materials"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01290","article-title":"The role of specialized pro-resolving mediators in cystic fibrosis airways disease","volume":"11","author":"Briottet","year":"2020","journal-title":"Front Pharmacol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"106618","DOI":"10.1016\/j.phrs.2022.106618","article-title":"Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study","volume":"187","author":"Chen","year":"2023","journal-title":"Pharmacol Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1159\/000527064","article-title":"The role of serum resolvin D1 levels in determining the presence and prognosis of ST-segment elevation myocardial infarction","volume":"31","author":"Karayi\u011fit","year":"2022","journal-title":"Med principles practice: Int J Kuwait University Health Sci Centre"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4787","article-title":"Pilot application of lipoxin A(4) analog and lipoxin A(4) receptor agonist in asthmatic children with acute episodes","volume":"14","author":"Kong","year":"2017","journal-title":"Exp Ther Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema","volume":"168","author":"Wu","year":"2013","journal-title":"Br J Dermatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax7964","article-title":"Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci Adv"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.03.029","article-title":"In situ neutrophil apoptosis and macrophage efferocytosis mediated by Glycyrrhiza protein nanoparticles for acute inflammation therapy","volume":"369","author":"Liu","year":"2024","journal-title":"J Controlled release: Off J Controlled Release Soc"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1039\/D1BM00481F","article-title":"Venetoclax nanomedicine alleviates acute lung injury via increasing neutrophil apoptosis","volume":"9","author":"Su","year":"2021","journal-title":"Biomaterials Sci"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303377110","article-title":"Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles","volume":"110","author":"Kamaly","year":"2013","journal-title":"Proc Natl Acad Sci United States America"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1589923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:12:05Z","timestamp":1747282325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1589923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":181,"alternative-id":["10.3389\/fimmu.2025.1589923"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1589923","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1589923"}}